iNO | Riociguat | ||||
Incremental dose | Single dose | ||||
0.5+1+1 mg | 1+2+2 mg | 1 mg | 2.5 mg | ||
Subjects n | 19 | 2 | 2 | 5 | 10 |
Adverse events# | 0 (0) | 1 (50) | 1 (50) | 1 (20) | 1 (10) |
Renal and urinary disorders | Micturition urgency¶ | Urinary retention¶ | |||
Vascular disorders | Hot flush+ | ||||
Nervous system disorders | Dizziness+ | ||||
Respiratory, thoracic and mediastinal disorders | Cough¶ | Nasal congestion+ |
Data are presented as n (%), unless otherwise stated. iNO: inhaled nitric oxide. #: all adverse events were mild in severity; ¶: not drug related; +: at least possibly drug related.